1. News
  2. Sector

  3. Pharma & Healthcare

Back to Top

HealthyDunia.com announces India Health & Wellness Awards 2014

India Infoline News Service  | Mumbai September 19, 2014 16:18 IST

The pan-India awards to be held on December 20th, will recognize the key players of Indias USD 140-billion Health & Wellness industry

Bayer plans to focus entirely on Life Science businesses

India Infoline News Service  | Mumbai September 19, 2014 12:15 IST

Employment levels are expected to remain stable over the next few years

Biocon stock up 2%

India Infoline News Service  | Mumbai September 19, 2014 09:53 IST

The stock has hit a high of Rs514 and a low of Rs506.

Silver Leaf Oak acquires 10% stake in Syngene International

India Infoline News Service  | Mumbai September 19, 2014 08:23 IST

Post the completion of this transaction, Biocon and BRL will jointly hold 85.54% stake in Syngene.

Cipla announces new license to Salix Pharmaceuticals for an innovative product

India Infoline News Service  | Mumbai September 18, 2014 17:21 IST

Under the agreement, Cipla has granted Salix exclusive rights under certain patent applications in the Rifaximin Complexes patent family controlled by Cipla.

CURA Technologies introduce its Dream Digital Radiography Systems

India Infoline News Service  | Mumbai September 18, 2014 16:50 IST

DReam offers a unique single detector design used in all positions without physical movement of detector reducing investment for 2 detectors.

Sun Pharma stock ends 2% higher

India Infoline News Service  | Mumbai September 18, 2014 12:01 IST

The stock has hit a high of Rs812 and a low of Rs800.

Piramal supports J&Ks disaster relief operations

India Infoline News Service  | Mumbai September 18, 2014 11:51 IST

Piramal Sarvajal is in the process of sending and setting up 10 Sarvajal water purification plants across Srinagar.

Sun Pharma and Merck enter into licensing agreement for Tildrakizumab

India Infoline News Service  | Mumbai September 18, 2014 09:10 IST

Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of U.S. $80 million.

Ranbaxy Lab receives Civil Investigative Demand from United States Department of Justice

India Infoline News Service  | Mumbai September 18, 2014 09:05 IST

The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation.

Gilead Briefs Nirmala Sitharaman about licensing agreements with Seven Generic Pharma Manufacturers

India Infoline News Service  | Mumbai September 17, 2014 16:58 IST

Sitharaman welcomed the development as this will result in expansion of access of these drugs to many more patients.

Apollo Hospitals Enterprise stock up on plans to buy Hetero Med Solutions

India Infoline News Service  | Mumbai September 17, 2014 16:36 IST

The stock has hit a high of Rs1139 and a low of Rs1111.

Glenmarks TRPA1 antagonist GRC 17536 shows positive data

India Infoline News Service  | Mumbai September 17, 2014 14:10 IST

A statistically significant and clinically relevant response was seen in a prospectively-identified, substantial sub-group of patients with moderate to severe pain who had relatively intact sensory responses as detected by a standardized testing methodology.

Hitachi India Developed extract precisely designated information from Electronic Medical Records

India Infoline News Service  | Mumbai September 17, 2014 13:57 IST

Hitachi India and Hitachi will continue to improve this extraction technology, and develop new technologies leading to the creation of advanced medical services.

Apollo Hospitals to acquire Hetero Med Solutions

India Infoline News Service  | Mumbai September 17, 2014 12:57 IST

Apollo Hospitals to acquire pharmacy stores business of Hetero Med Solutions Ltd as a business undertaking on a slump sale basis

Clariant doubles capacity for the pigments in Roha

India Infoline News Service  | Mumbai September 17, 2014 10:12 IST

Clariant expand its doubles capacity there for pigment preparations.

Aurobindo Pharma gets USFDA nod for Amoxicillin generic, stock up 1%

India Infoline News Service  | Mumbai September 17, 2014 09:59 IST

The stock opened at Rs. 874 as against the previous close of Rs. 854. It hit a high of Rs. 880 and a low of Rs. 857 on BSE

Apollo Hospitals in talks to buy Hetero Pharmacy: reports

India Infoline News Service  | Mumbai September 17, 2014 08:38 IST

Report stated that the deal may be valued at around Rs 300 crore.

Aurobindo Pharma receives USFDA Approval for Amoxicillin for Oral Suspension

India Infoline News Service  | Mumbai September 16, 2014 23:24 IST

ANDAs has been approved out of Unit XII, Semi-Synthetic Penicillin formulation facility in Hyderabad.

Back to Top

 

 
 
 
Recent Reports
News